BRAF and colorectal carcinoma: In addition, selection of patients through the use of predictive biomarkers may be reasonable strategies, and predictive biomarkers should be selected depend on the form of CRC, more specifically; BRAF appears to be a strong prognostic factor for OS after relapse, particularly in MS-L/S stage II patients [33].